Related Experiment Videos
Mendelian disorders deserve more attention.
Stylianos E Antonarakis1, Jacques S Beckmann
1Department of Genetic Medicine and Development, University of Geneva Medical School, and University Hospital of Geneva, 1 rue Michel-Servet, 1211 Geneva, Switzerland. Stylianos.Antonarakis@medecine.unige.ch
Nature Reviews. Genetics
|March 15, 2006
Summary
Studying inherited monogenic diseases offers crucial insights into gene regulation and diagnostics. Neglecting these Mendelian disorders risks overlooking their potential to illuminate the causes of common, complex diseases.
Area of Science:
- Genetics
- Molecular Biology
- Medical Research
Background:
- Inherited monogenic diseases have historically advanced understanding of pathogenic mutations and gene regulation.
- Current research focus has shifted from monogenic disorders to multifactorial common diseases.
- Monogenic diseases, though rare, provide foundational knowledge for genetic research.
Purpose of the Study:
- To emphasize the continued importance of studying monogenic diseases.
- To highlight the potential of Mendelian disorders in understanding complex traits.
- To advocate for a balanced research approach in genetics.
Main Methods:
- Review of historical contributions of monogenic disease research.
- Analysis of the shift in research focus towards common complex diseases.
- Conceptual framework for linking Mendelian genetics to complex trait aetiology.
Main Results:
- Monogenic diseases have been instrumental in developing diagnostic tools and understanding gene function.
- The shift towards common diseases may lead to the neglect of valuable insights from rare genetic disorders.
- Mendelian disorders offer unique models for dissecting genetic underpinnings of biological mechanisms.
Conclusions:
- Continued investigation of monogenic diseases is essential for advancing genetic knowledge.
- Understanding Mendelian disorders can significantly contribute to unraveling the aetiology of complex traits.
- A comprehensive genetic research strategy should integrate insights from both rare and common diseases.